Vitamin A (Retinol)

What is Vitamin A (Retinol)?

A retinol blood test measures vitamin A stored in the liver and released into blood.

A blood retinol test measures retinol, the transport form of vitamin A that circulates bound to retinol-binding protein (RBP) and transthyretin. Vitamin A plays roles in vision, immune function, and epithelial cell health, among others, according to the National Institutes of Health, Office of Dietary Supplements (updated March 10, 2025). What sets retinol apart from most other vitamins on a lab panel is where the body keeps it. Vitamin A is fat-soluble, and the body stores most of it in the liver as retinyl esters. That storage depot acts as a buffer: the liver releases retinol into blood at a fairly steady rate, largely independent of what you ate that day. Because of this buffering, blood retinol does not decline until vitamin A levels in the liver and other storage sites are almost depleted, and by the same logic it doesn't rise substantially until those stores are considerably overloaded, according to the NIH Office of Dietary Supplements. That's the direct explanation for why retinol is a poor early-warning marker. It isn't measuring day-to-day sufficiency; it's measuring what's left after the liver's reserve has already been drawn down or exceeded. It's also why clinicians order it narrowly: rather than routine screening, a retinol test is typically requested when deficiency (night blindness, dry eyes, recurrent infections) or toxicity is already suspected on clinical grounds, not as a general wellness check. The toxicity side is where vitamin A differs sharply from vitamins that are simply excreted in excess. Because the liver stores rather than clears surplus vitamin A, high intakes accumulate. Acute toxicity can appear within days to weeks of one or a few very high doses, typically more than 100 times the RDA, and can cause severe headache, blurred vision, and, in severe cases, increased pressure in the fluid around the brain. Regular high-dose intake over time is linked to dry skin, joint pain, fatigue, and abnormal liver test results. The most consequential risk sits in pregnancy. High intakes of preformed vitamin A, along with retinoid medications such as isotretinoin used for severe acne, are established teratogens, associated with malformations of the eyes, skull, lungs, and heart (Rothman et al., New England Journal of Medicine, 1995). That's why US guidance caps supplemental preformed vitamin A during pregnancy and why isotretinoin prescribing is tightly restricted through a mandatory pregnancy-prevention program. Even so, a 2025 analysis of the FDA's iPLEDGE program found fetal exposure hasn't been eliminated: isotretinoin users still had a pregnancy incidence of 15.7 per 1,000 person-years in Medicaid data and 3.3 per 1,000 person-years in commercial insurance data, well below the rate among topical retinoid users but not zero (JAMA Internal Medicine, published online July 21, 2025). That's public-health context on how hard this specific risk has been to eliminate at a population level, not a comment on any individual's situation.

Typical reference context

Source: NIH Office of Dietary Supplements, Vitamin A and Carotenoids fact sheet, updated March 10, 2025. Labs vary in exact cutoffs and units, so compare a result against the range printed on that specific report.

The Tolerable Upper Intake Level for preformed vitamin A is 3,000 mcg RAE a day (10,000 IU) for adults, including pregnant and lactating women.

What changed recently

A 2024 British Journal of Nutrition study (published online September 11, 2023) challenged healthy adults with norovirus and tracked retinol and RBP through the acute illness. Retinol and RBP are expected to circulate in a roughly 1:1 molar ratio, but the median ratio measured 0.68, in both infected and uninfected participants, and stayed below the expected value even after applying the standard BRINDA statistical correction for inflammation (adjusted ratio: 0.71). The authors concluded that inflammation alone doesn't explain the gap, meaning today's RBP-based cutoffs may not fully capture true vitamin A status during or after an infection, a limitation researchers are still working out (Victor, Leon, and Williams, British Journal of Nutrition, 2024).

Separately, the July 2025 JAMA Internal Medicine analysis of iPLEDGE data above is the most current large-scale look at how much residual pregnancy risk remains around retinoid teratogenicity despite an active mitigation program, which matters directly for anyone weighing high-dose vitamin A or retinoid products during reproductive years.

Tests often checked alongside this

Retinol-binding protein (RBP) is usually interpreted together with retinol, since retinol travels bound to RBP and low RBP can pull measured retinol down independent of liver stores. Zinc matters here too, since the liver needs zinc to synthesize RBP, so zinc status and vitamin A status are metabolically linked. C-reactive protein (CRP) or other inflammation markers get ordered to help interpret a retinol result, since acute inflammation can shift measured retinol. A liver function panel is often checked alongside when toxicity, not deficiency, is the concern.

What to ask your doctor

• If I'm pregnant or might become pregnant, is anything I'm taking, including supplements, close to or above the vitamin A upper limit?
• What reference range did the lab use, and could recent illness or inflammation have affected this specific result?
• Given that this test is usually reserved for suspected deficiency or toxicity, is it the right test for what we're checking?

This glossary entry is for informational purposes only and is not a substitute for professional medical advice. Read our Terms of Use.

Frequently asked questions